Development

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Videos

Pharmaceutical Technology Europe® spoke with Gustavo Ferrer from Dr. Ferrer BioPharma, a US company focused on innovative intranasal medications, at the inaugural Start-Up Market on the show floor at CPHI Barcelona 2023.

Improving Intranasal Treatments with Dr. Ferrer BioPharma at CPHI Barcelona

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Articles

Predictive modeling facilitates the identification of coformers, cocrystal components, and complexing agents.

Predictive Modeling for Formulation Development: Coformers, Cocrystals, Complexes

Pharmaceutical Technology Europe® spoke with Dr. Tom Kamperman from IamFluidics, a Dutch high-tech company that develops customized microencapsulation solutions, at the inaugural Start-Up Market on the show floor at CPHI Barcelona 2023.

Gently Encapsulating APIs with IamFluidics at CPHI Barcelona

Feliza Mirasol is the science editor for 

Sara Fathollahi, PhD, product application specialist at DFE Pharma, makes the case of how excipient suppliers can support the transition from batch to continuous manufacturing.

A Look at How Excipient Suppliers Can Support Adoption of Continuous Manufacturing (AAPS PharmSci 360)

Dr. Nikunj Patel is a senior director of PBPK Consultancy Services in the Simcyp division of Certara. Nikunj helps clients with advanced PBPK modeling to expedite internal decision making, support biowaivers via virtual bioequivalence assessments, and develop model-informed regulatory strategies for novel products, generic formulations, scale-up and post-approval changes (SUPAC), and justification of dissolution specifications. He has more than more 13 years’ experience in computer-aided drug design and PKPD modeling, including 10+ years’ experience focusing on PBPK modeling.

Ellen Leinfuss is senior vice president and chief commercial officer for Certara’s Simcyp Division. Simcyp is the global leader in mechanistic modeling, employing its Simcyp Simulator physiologically based pharmacokinetic (PBPK) and quantitative systems pharmacology (QSP) immunogenicity, immuno-oncology, vaccine, and gene therapy modeling and simulation platforms. Ellen has worked for Certara for eight years, serving for several years as chief marketing officer for the corporation. She has a BA in chemistry and an MBA in marketing.

Model informed formulation development uses in-silico modeling and simulation to identify and/or refine promising formulations faster and cheaper, support formulation strategy and increasingly, demonstrate virtual bioequivalence and obtain biowaivers.

Advancing Oral Drug Development Using MIFD

Jason Hansell is Junior Applications Technologist at Colorcon Inc. (PA, USA).

Shahrzad Missaghi, PhD, is senior manager—Product Development at Colorcon.

A new generation of interactive formulation development platforms can leave trial and error in the formulation process in the past.

The New Digital Era for Formulation Development

The Start-Up Market at CPHI Barcelona will bring together 27 start-ups, innovators, and small enterprises from across the pharma landscape.

Innovative Start-Ups at CPHI Barcelona

When considering manufacturing and the growth of drug formulation, it is evident that there has been change and many new advancements introduced to make processes more efficient. 

Trends in Formulation for Highly Potent Drugs

Sherma Ellis Daal, brand director, Pharma at Informa Markets, gives a preview of CPHI Barcelona 2023. 

Welcome to CPHI Barcelona

Bikash Chatterjee is President and Chief Technology Officer at Pharmatech Associates USA.

CPHI’s Annual Report predicts huge impact of AI on drug development and manufacturing.